These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34448199)

  • 1. Pathogen-reduced platelets in pediatric and neonatal patients: Demographics, transfusion rates, and transfusion reactions.
    Lasky B; Nolasco J; Graff J; Ward DC; Ziman A; McGonigle AM
    Transfusion; 2021 Oct; 61(10):2869-2876. PubMed ID: 34448199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen-reduced platelets.
    Bahar B; Schulz WL; Gokhale A; Spencer BR; Gehrie EA; Snyder EL
    Br J Haematol; 2020 Feb; 188(3):465-472. PubMed ID: 31566724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Utilization and Transfusion Reactions in Pediatric Patients Transfused with Conventional or Pathogen Reduced Platelets.
    Schulz WL; McPadden J; Gehrie EA; Bahar B; Gokhale A; Ross R; Price N; Spencer BR; Snyder E
    J Pediatr; 2019 Jun; 209():220-225. PubMed ID: 30885645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, active haemovigilance study with combined cohort analysis of 19,175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment.
    Knutson F; Osselaer J; Pierelli L; Lozano M; Cid J; Tardivel R; Garraud O; Hervig T; Domanovic D; Cukjati M; Gudmundson S; Hjalmarsdottir IB; Castrillo A; Gonzalez R; Brihante D; Santos M; Schlenke P; Elliott A; Lin JS; Tappe D; Stassinopoulos A; Green J; Corash L
    Vox Sang; 2015 Nov; 109(4):343-52. PubMed ID: 25981525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of pathogen-reduced platelet concentrates in children with cancer: a retrospective cohort study.
    Trakhtman P; Karpova O; Balashov D; Kurnikova E; Pirumova V; Starostin N; Rumiantsev A
    Transfusion; 2016 Mar; 56 Suppl 1():S24-8. PubMed ID: 27001357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immature platelet counts in transfused platelet units given to neonates.
    Roncin KL; Reeves HM; Maitta RW
    Clin Chim Acta; 2024 Jul; 561():119760. PubMed ID: 38844020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and safety of riboflavin and UV light-treated platelet transfusions in children over a five-year period: focusing on neonates.
    Jimenez-Marco T; Garcia-Recio M; Girona-Llobera E
    Transfusion; 2019 Dec; 59(12):3580-3588. PubMed ID: 31587287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of platelet transfusion treated with amotosalen/UVA pathogen inactivation technology (INTERCEPT
    Ladaique P; Etienne JM; Pedini P; Chiaroni J; Vey N; Picard C; Chabrieres C
    Blood Transfus; 2023 Sep; 21(5):400-408. PubMed ID: 36795348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment.
    Osselaer JC; Cazenave JP; Lambermont M; Garraud O; Hidajat M; Barbolla L; Tardivel R; Defoin L; Waller C; Mendel I; Raidot JP; Kandel G; De Meuter R; Fabrigli P; Dehenau D; Arroyo JL; Padrón F; Gouezec H; Corral M; Jacquet M; Sundin D; Lin L; Corash L
    Vox Sang; 2008 May; 94(4):315-23. PubMed ID: 18248574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of platelet storage duration on clinical outcomes and incremental platelet change in critically ill children.
    Nellis ME; Spinella PC; Tucci M; Stanworth SJ; Steiner ME; Cushing MM; Davis PJ; Karam O;
    Transfusion; 2020 Dec; 60(12):2849-2858. PubMed ID: 32959409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment.
    Osselaer JC; Messe N; Hervig T; Bueno J; Castro E; Espinosa A; Accorsi P; Junge K; Jacquet M; Flament J; Corash L
    Transfusion; 2008 Jun; 48(6):1061-71. PubMed ID: 18346019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransfusion platelet increments after different platelet products in neonates: a retrospective cohort study.
    Honohan A; van't Ende E; Hulzebos C; Lopriore E; van't Verlaat E; Govaert P; Brand A; van der Bom J
    Transfusion; 2013 Dec; 53(12):3100-9. PubMed ID: 23441721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation.
    Vande Vusse LK; Madtes DK; Guthrie KA; Gernsheimer TB; Curtis JR; Watkins TR
    Transfusion; 2014 Apr; 54(4):1071-80. PubMed ID: 24033082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a patient blood management program in hematopoietic stem cell transplantation (Editorial, p. 2763).
    Warner MA; Jambhekar NS; Saadeh S; Jacob EK; Kreuter JD; Mundell WC; Marquez A; Higgins AA; Madde NR; Hogan WJ; Kor DJ
    Transfusion; 2019 Sep; 59(9):2840-2848. PubMed ID: 31222775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion-related adverse events in the Platelet Dose study.
    Kaufman RM; Assmann SF; Triulzi DJ; Strauss RG; Ness P; Granger S; Slichter SJ
    Transfusion; 2015 Jan; 55(1):144-53. PubMed ID: 25065959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components.
    Sigle JP; Infanti L; Studt JD; Martinez M; Stern M; Gratwohl A; Passweg J; Tichelli A; Buser AS
    Transfusion; 2013 Aug; 53(8):1788-97. PubMed ID: 23176347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient and product factors affecting platelet transfusion results.
    Heim D; Passweg J; Gregor M; Buser A; Theocharides A; Arber C; Meyer-Monard S; Halter J; Tichelli A; Gratwohl A
    Transfusion; 2008 Apr; 48(4):681-7. PubMed ID: 18208413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age of platelet concentrates and time to the next transfusion.
    Caram-Deelder C; van der Bom JG; Putter H; Leyte A; Kerkhof DV; Evers D; Beckers EA; Weerkamp F; Hudig F; Zwaginga JJ; Rondeel JMM; de Vooght KMK; Péquériaux NCV; Visser O; Wallis JP; Middelburg RA
    Transfusion; 2018 Jan; 58(1):121-131. PubMed ID: 29090466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of acute transfusion reactions to platelets in hospitalized pediatric patients based on the US hemovigilance reporting system.
    Li N; Williams L; Zhou Z; Wu Y
    Transfusion; 2014 Jun; 54(6):1666-72. PubMed ID: 24410992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.